- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
From Benzinga
Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
December 01, 2021
From Benzinga
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
From Motley Fool
What Are the Top COVID Plays for 2022?
November 19, 2021
From Motley Fool
Why Connect Biopharma Stock Is Crashing Today
November 19, 2021
From Motley Fool
The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
November 19, 2021
From Benzinga
These 3 High-Yield Dividend Stocks Are Growing at Blazing Speeds
November 18, 2021
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
November 13, 2021
From Motley Fool
A Pfizer Drug Moves Closer to Approval in Another Important Indication
November 02, 2021
From Motley Fool
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
From Benzinga
Earnings Scheduled For October 28, 2021
October 28, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
From Benzinga
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
2 Stocks That Could Grow Your Portfolio Over the Next Decade
October 20, 2021
From Motley Fool
From Motley Fool
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
From Motley Fool
Tech Sell-Off: 2 Unstoppable Stocks to Buy Now
October 14, 2021
From Motley Fool
Pfizer Just Scored Another Key Regulatory Approval
October 14, 2021
From Motley Fool
Got $5,000? 3 Top Dividend Stocks to Buy Right Now
October 13, 2021
From Motley Fool
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
From Motley Fool
From MarketWatch
Regeneron Could Have a Big Catalyst Coming in 2022
October 09, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.